Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Loss of ERα in breast cancer correlates with poor prognosis, increased recurrence rates, and higher incidence of metastasis. Epigenetic silencing of E-cadherin (loss of which is associated with more invasive phenotype) is observed in metastatic cell lines and invasive breast cancers. Here, we are showing that entinostat (ENT) can reverse epithelial to mesenchymal transition (EMT), which is considered to be a first step in the process of metastases formation. Triple-negative breast cancer cells such as MDA-MB-231 and Hs578T show a basal phenotype characterized by loss of E-cadherin expression and higher expression of mesenchymal markers such as N-cadherin and vimentin along with transcriptional repressors such as twist and snail. When MDA-MB-231 and Hs578T cells or tumors were treated with ENT, E-cadherin transcription was increased along with reduction in N-cadherin mRNA expression. Chromatin immunoprecipitation assay showed that treatment of MDA-MB-231 and Hs578T cells increased the activation of E-cadherin promoter by reducing the association of twist and snail with the E-cadherin (CDH1) promoter and downregulated both the snail and twist. ENT also inhibited cell migration in vitro. In addition, phosphorylation of vimentin was increased, as well as remodeling of vimentin filaments. ENT treatment also reduced formation of tubulin-based microtentacles, which help floating cells attach to other surfaces. These findings suggest that ENT can reverse EMT and may reduce the formation of metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Entinostat, an oral HDAC inhibitor, induces protein lysine acetylation in preclinical models, which leads to downregulation of estrogen-independent growth factor signaling pathways and normalization of estrogen receptor levels.9,10”
Citations
The citation lists are queued
They are fetched later and appear here then.
References 40 · Cited by 86
Metadata
- Authors
- Shah, P., Gau, Y., & Sabnis, G.
- Affiliations
- University of Maryland, Baltimore (US)
- Corresponding author
- Sabnis, Gauri
- ORCID
- Sabnis, Gauri
- Venue
- Breast Cancer Research and Treatment
- Published
- 2013-12-05
- Volume
- 143
- Issue
- 1
- Pages
- 99-111
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W2035131746
- Cited by
- 86
- References
- 40
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 5 · 2021: 13 · 2020: 3 · 2019: 10 · 2018: 10 · 2017: 6 · 2016: 6 · 2015: 3 · 2014: 9
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Breast Cancer Research and Treatment (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Susan G. Komen
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- entinostat, histone deacetylase inhibitors, epithelial-mesenchymal transition, E-cadherin, breast cancer, triple-negative breast cancer, metastasis, epigenetic silencing, Twist, snails, N-cadherin, vimentin, cell migration, MDA-MB-231 cells, Hs578T
- MeSH terms
- Snail Family Transcription Factors, Benzamides, Breast Neoplasms, Cell Movement, DNA Helicases, DNA-Binding Proteins, Female, Humans, Promoter Regions, Genetic, Protein Binding, Pyridines, Transcription Factors, Cadherins, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, Twist-Related Protein 1, Histone Deacetylase Inhibitors, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin. https://app.cochat.ai/papers/10.1007/s10549-013-2784-7
- The paper
- Shah, P., Gau, Y., & Sabnis, G. (2014). Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-013-2784-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.